<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">31381864</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>200</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Patterns of VC Decline in Amyotrophic Lateral Sclerosis. A More Robust Prognostication?</ArticleTitle><Pagination><StartPage>1461</StartPage><EndPage>1462</EndPage><MedlinePgn>1461-1462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201907-1440ED</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baydur</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep MedicineUniversity of Southern CaliforniaLos Angeles, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Am J Respir Crit Care Med. 2019 Jul 19;:</RefSource><PMID Version="1">31322417</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31381864</ArticleId><ArticleId IdType="pmc">PMC6909827</ArticleId><ArticleId IdType="doi">10.1164/rccm.201907-1440ED</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andrews JA, Meng L, Kulke SF, Rudnicki SA, Wolff AA, Bozik ME, et al. Association between decline in slow vital capacity and respiratory insufficiency, use of assisted ventilation, tracheostomy, or death in patients with amyotrophic lateral sclerosis. JAMA Neurol. 2018;75:58&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833488</ArticleId><ArticleId IdType="pubmed">29181534</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Matias T, Coelho F, Evangelista T, Pinto A, Lu&#xed;s ML. Motor neuron disease presenting with respiratory failure. J Neurol Sci. 1996;139:117&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">8899670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackrivo J, Hansen-Flaschen J, Jones BL, Wileyto EP, Schwab RJ, Elman L, et al. Classifying patients with amyotrophic lateral sclerosis by changes in FVC: a group-based trajectory analysis. Am J Respir Crit Care Med. 2019;200:1513&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909832</ArticleId><ArticleId IdType="pubmed">31322417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackrivo J, Hansen-Flaschen J, Wileyto EP, Schwab RJ, Elman L, Kawut SM. Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis. Eur Respir J. 2019;53:1802237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684229</ArticleId><ArticleId IdType="pubmed">30728207</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">20192788</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Stein TD, Kiernan PT, Alvarez VE. The neuropathology of chronic traumatic encephalopathy. Brain Pathol. 2015;25:350&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526170</ArticleId><ArticleId IdType="pubmed">25904048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, O&#x2019;Reilly EJ, Weisskopf MG, Logroscino G, McCullough ML, Thun MJ, et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol. 2011;68:207&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3319086</ArticleId><ArticleId IdType="pubmed">21320987</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael J-C, Chevret S, Chastang C, Bouvet F French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. Lancet. 1994;343:1600&#x2013;1604.</Citation><ArticleIdList><ArticleId IdType="pubmed">7911921</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>